Study Site | Observed PE (%, 95% CI) | Model PE (%) | ||
---|---|---|---|---|
(a) No immunity | (b) Baseline | (c) Alternative based on immunity to severe disease | ||
Ifakara | 58.8 (40.8–71.3) | 32.4 | 23.0 | 26.4 |
Manhica | 20.1 (2.1–34.9) | 38.6 | 32.0 | 34.0 |
Navrongo | 29.3 (17.7–39.5) | 38.5 | 31.9 | 34.1 |
Lamebarene | 22.0 (-25.4–51.5) | 28.2 | 23.6 | 26.0 |
Kumasi | 20.9 (8.9–31.3) | 38.0 | 25.9 | 30.3 |
Tamale | 33.3 (20.7–43.8) | 29.7 | 24.9 | 27.4 |